ResMed Inc. (0KW4.L)
USD 239.46
(1.1%)
USD 239.46
(1.1%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 1.6 Billion USD | 12.86% |
| 2023 | 1.35 Billion USD | 12.18% |
| 2022 | 1.17 Billion USD | 7.33% |
| 2021 | 1.09 Billion USD | 12.4% |
| 2020 | 990.43 Million USD | 17.35% |
| 2019 | 705.79 Million USD | 20.73% |
| 2018 | 680.22 Million USD | 16.48% |
| 2017 | 568.88 Million USD | 10.96% |
| 2016 | 522.71 Million USD | 9.36% |
| 2015 | 482.29 Million USD | 15.63% |
| 2014 | 484.86 Million USD | 17.13% |
| 2013 | 469.78 Million USD | 17.59% |
| 2012 | 422.58 Million USD | 7.1% |
| 2011 | 374.32 Million USD | 16.74% |
| 2010 | 322.15 Million USD | 22.17% |
| 2009 | 190.31 Million USD | -0.58% |
| 2008 | 204.83 Million USD | 49.22% |
| 2007 | 90.16 Million USD | -21.8% |
| 2006 | 174.04 Million USD | 18.56% |
| 2005 | 136.89 Million USD | 43.8% |
| 2004 | 85.36 Million USD | 32.76% |
| 2003 | 79.82 Million USD | 272.76% |
| 2002 | -40.83 Million USD | -166.06% |
| 2001 | 52.16 Million USD | 73.16% |
| 2000 | 39.38 Million USD | 24.71% |
| 1999 | 29.9 Million USD | 40.81% |
| 1998 | 21 Million USD | 175.31% |
| 1997 | 10.9 Million USD | 305.0% |
| 1996 | 4.9 Million USD | -16.67% |
| 1995 | 3.4 Million USD | 118.18% |
| 1994 | 1.6 Million USD | 266.67% |
| 1993 | 900 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - USD | 19.47% |
| 2024 Q2 | 456.92 Million USD | 14.68% |
| 2024 Q1 | 288.99 Million USD | 5.04% |
| 2024 Q4 | 435.97 Million USD | -1.68% |
| 2024 Q3 | 429.22 Million USD | 9.3% |
| 2023 Q2 | 342.55 Million USD | 7.13% |
| 2023 FY | - USD | 12.18% |
| 2023 Q4 | 333.76 Million USD | -3.83% |
| 2023 Q1 | 319.77 Million USD | 6.45% |
| 2023 Q3 | 347.04 Million USD | 1.31% |
| 2022 Q1 | 309.53 Million USD | 7.73% |
| 2022 FY | - USD | 7.33% |
| 2022 Q4 | 300.4 Million USD | 5.08% |
| 2022 Q3 | 285.87 Million USD | -4.17% |
| 2022 Q2 | 298.31 Million USD | -3.62% |
| 2021 Q1 | 266.78 Million USD | -0.73% |
| 2021 Q3 | 271.3 Million USD | -5.51% |
| 2021 FY | - USD | 12.4% |
| 2021 Q2 | 287.13 Million USD | 7.63% |
| 2021 Q4 | 287.31 Million USD | 5.9% |
| 2020 Q2 | 242.09 Million USD | 12.59% |
| 2020 Q4 | 268.75 Million USD | 1.81% |
| 2020 FY | - USD | 17.35% |
| 2020 Q3 | 263.96 Million USD | 9.03% |
| 2020 Q1 | 215.01 Million USD | -18.82% |
| 2019 Q2 | 205.35 Million USD | 17.64% |
| 2019 Q4 | 264.86 Million USD | 33.28% |
| 2019 Q1 | 174.55 Million USD | -9.84% |
| 2019 Q3 | 198.72 Million USD | -3.23% |
| 2019 FY | - USD | 20.73% |
| 2018 Q2 | 175.39 Million USD | 23.4% |
| 2018 FY | - USD | 16.48% |
| 2018 Q4 | 193.6 Million USD | 3.24% |
| 2018 Q1 | 142.12 Million USD | -8.62% |
| 2018 Q3 | 187.52 Million USD | 6.92% |
| 2017 Q3 | 151.77 Million USD | -11.04% |
| 2017 Q2 | 170.6 Million USD | 39.93% |
| 2017 Q4 | 155.52 Million USD | 2.48% |
| 2017 FY | - USD | 10.96% |
| 2017 Q1 | 121.92 Million USD | -18.44% |
| 2016 Q3 | 131.31 Million USD | -8.37% |
| 2016 Q2 | 143.32 Million USD | 23.1% |
| 2016 Q1 | 116.42 Million USD | -9.95% |
| 2016 FY | - USD | 9.36% |
| 2016 Q4 | 149.48 Million USD | 13.84% |
| 2015 FY | - USD | 15.63% |
| 2015 Q4 | 129.29 Million USD | 4.5% |
| 2015 Q3 | 123.72 Million USD | -3.35% |
| 2015 Q1 | 113.25 Million USD | -0.25% |
| 2015 Q2 | 128.01 Million USD | 13.03% |
| 2014 Q4 | 113.54 Million USD | 5.96% |
| 2014 Q2 | 107.47 Million USD | 8.24% |
| 2014 Q1 | 99.29 Million USD | 12.03% |
| 2014 FY | - USD | 17.13% |
| 2014 Q3 | 107.15 Million USD | -0.29% |
| 2013 Q1 | 83.12 Million USD | -10.28% |
| 2013 Q4 | 88.63 Million USD | -10.13% |
| 2013 FY | - USD | 17.59% |
| 2013 Q3 | 98.63 Million USD | 4.29% |
| 2013 Q2 | 94.57 Million USD | 13.77% |
| 2012 Q3 | 82.33 Million USD | 31.84% |
| 2012 Q4 | 92.64 Million USD | 12.53% |
| 2012 Q1 | 65.94 Million USD | -8.15% |
| 2012 Q2 | 62.44 Million USD | -5.3% |
| 2012 FY | - USD | 7.1% |
| 2011 Q2 | 69.4 Million USD | 6.18% |
| 2011 Q1 | 65.36 Million USD | -17.71% |
| 2011 FY | - USD | 16.74% |
| 2011 Q4 | 71.8 Million USD | -64.28% |
| 2011 Q3 | 200.99 Million USD | 189.61% |
| 2010 Q3 | 62.78 Million USD | 4.57% |
| 2010 Q2 | 60.04 Million USD | -8.91% |
| 2010 Q1 | 65.91 Million USD | -12.58% |
| 2010 FY | - USD | 22.17% |
| 2010 Q4 | 79.42 Million USD | 26.51% |
| 2009 Q3 | 66.59 Million USD | 20.83% |
| 2009 Q2 | 55.11 Million USD | 6.01% |
| 2009 Q1 | 51.99 Million USD | 3.96% |
| 2009 FY | - USD | -0.58% |
| 2009 Q4 | 75.4 Million USD | 13.23% |
| 2008 Q1 | 51.01 Million USD | 9.29% |
| 2008 FY | - USD | 49.22% |
| 2008 Q4 | 50.01 Million USD | -4.45% |
| 2008 Q3 | 52.34 Million USD | 2.6% |
| 2008 Q2 | 51.01 Million USD | 0.01% |
| 2007 Q1 | 46.59 Million USD | -7.39% |
| 2007 FY | - USD | -21.8% |
| 2007 Q3 | -8.96 Million USD | -117.02% |
| 2007 Q2 | 52.66 Million USD | 13.02% |
| 2007 Q4 | 46.67 Million USD | 620.65% |
| 2006 Q2 | 41.45 Million USD | 15.25% |
| 2006 FY | - USD | 18.56% |
| 2006 Q1 | 35.97 Million USD | -19.81% |
| 2006 Q4 | 50.31 Million USD | 6.12% |
| 2006 Q3 | 47.41 Million USD | 14.36% |
| 2005 Q2 | 33.67 Million USD | 9.73% |
| 2005 Q4 | 44.86 Million USD | 18.02% |
| 2005 FY | - USD | 43.8% |
| 2005 Q3 | 38.01 Million USD | 12.87% |
| 2005 Q1 | 30.69 Million USD | 2.41% |
| 2004 Q4 | 29.97 Million USD | 10.9% |
| 2004 Q1 | 23.72 Million USD | 20.09% |
| 2004 Q3 | 27.02 Million USD | 22.76% |
| 2004 FY | - USD | 32.76% |
| 2004 Q2 | 22.01 Million USD | -7.22% |
| 2003 Q1 | 18.48 Million USD | 120.77% |
| 2003 Q3 | 20.49 Million USD | -1.75% |
| 2003 Q2 | 19.3 Million USD | 1.12% |
| 2003 FY | - USD | 272.76% |
| 2003 Q4 | 21.54 Million USD | 3.51% |
| 2002 Q2 | 16 Million USD | 3.1% |
| 2002 Q4 | -88 Million USD | -677.73% |
| 2002 FY | - USD | -166.06% |
| 2002 Q3 | 15.44 Million USD | -0.47% |
| 2002 Q1 | 15.71 Million USD | 73.6% |
| 2001 Q2 | 11.57 Million USD | 7.98% |
| 2001 Q4 | 9.67 Million USD | -73.48% |
| 2001 FY | - USD | 73.16% |
| 2001 Q1 | 11.07 Million USD | 2.34% |
| 2001 Q3 | 16.1 Million USD | 208.04% |
| 2000 Q1 | 8.84 Million USD | -5.32% |
| 2000 Q2 | 10 Million USD | 17.98% |
| 2000 Q4 | 10.28 Million USD | 2.8% |
| 2000 Q3 | 10.21 Million USD | -7.77% |
| 2000 FY | - USD | 24.71% |
| 1999 Q4 | 8.5 Million USD | 16.05% |
| 1999 FY | - USD | 40.81% |
| 1999 Q1 | 6.3 Million USD | -10.53% |
| 1999 Q2 | 7.1 Million USD | 4.41% |
| 1999 Q3 | 8 Million USD | 14.08% |
| 1998 Q1 | 3.5 Million USD | -6.67% |
| 1998 Q4 | 6.5 Million USD | 46.15% |
| 1998 Q3 | 5.6 Million USD | -20.0% |
| 1998 Q2 | 5.4 Million USD | 132.14% |
| 1998 FY | - USD | 175.31% |
| 1997 Q2 | 2.5 Million USD | 111.11% |
| 1997 Q1 | 2 Million USD | 50.0% |
| 1997 Q3 | 2.9 Million USD | 21.05% |
| 1997 Q4 | 3.4 Million USD | 30.43% |
| 1997 FY | - USD | 305.0% |
| 1996 FY | - USD | -16.67% |
| 1996 Q4 | 1.8 Million USD | 20.0% |
| 1996 Q3 | 1.3 Million USD | -93.67% |
| 1996 Q1 | 6.7 Million USD | 147.86% |
| 1996 Q2 | 7.9 Million USD | 17.91% |
| 1995 Q1 | 5.6 Million USD | 160.87% |
| 1995 Q3 | 5.6 Million USD | 0.0% |
| 1995 Q4 | -14 Million USD | -350.0% |
| 1995 FY | - USD | 118.18% |
| 1995 Q2 | 5.6 Million USD | 0.0% |
| 1994 FY | - USD | 266.67% |
| 1994 Q4 | -9.2 Million USD | -362.86% |
| 1994 Q2 | 3.5 Million USD | 0.0% |
| 1994 Q1 | 3.5 Million USD | 170.0% |
| 1994 Q3 | 3.5 Million USD | 0.0% |
| 1993 Q1 | 1.9 Million USD | 0.0% |
| 1993 Q4 | -5 Million USD | -363.16% |
| 1993 Q3 | 1.9 Million USD | 0.0% |
| 1993 Q2 | 1.9 Million USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Phreesia, Inc. | -102.94 Million USD | 1654.549% |
| Accuray Incorporated | 9 Million USD | -17663.681% |
| Align Technology, Inc. | 799.03 Million USD | -100.282% |
| Elevance Health Inc. | 10.49 Billion USD | 84.744% |
| AxoGen, Inc. | -13.32 Million USD | 12107.278% |
| Boston Scientific Corporation | 3.61 Billion USD | 55.706% |
| CVS Health Corporation | 18.17 Billion USD | 91.196% |
| Cardinal Health, Inc. | 1.97 Billion USD | 19.094% |
| Centene Corporation | -463 Million USD | 445.644% |
| DaVita Inc. | 2.34 Billion USD | 31.798% |
| HCA Healthcare, Inc. | 12.72 Billion USD | 87.42% |
| Hologic, Inc. | 1.29 Billion USD | -23.463% |
| Humana Inc. | -561 Million USD | 385.264% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | -31.426% |
| Laboratory Corporation of America Holdings | 1.34 Billion USD | -18.596% |
| Masimo Corporation | 236.7 Million USD | -576.101% |
| McKesson Corporation | 4.66 Billion USD | 65.71% |
| Patterson Companies, Inc. | 374.75 Million USD | -327.033% |
| Quest Diagnostics Incorporated | 1.73 Billion USD | 7.602% |
| Henry Schein, Inc. | 943 Million USD | -69.706% |
| Teladoc Health, Inc. | 153.99 Million USD | -939.196% |
| Universal Health Services, Inc. | 1.74 Billion USD | 8.208% |
| Veeva Systems Inc. | 429.33 Million USD | -272.747% |
| Baxter International Inc. | 2.77 Billion USD | 42.351% |
| Becton, Dickinson and Company | 4.27 Billion USD | 62.565% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 33.155% |
| Danaher Corporation | 7.49 Billion USD | 78.659% |
| Stryker Corporation | 5.16 Billion USD | 68.986% |
| Medtronic plc | 9.05 Billion USD | 82.329% |